InsidersTradesSigma
Track the 엘앤씨바이오 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤씨바이오 has recorded 6 public disclosures. Market capitalisation: €1,182.7bn. The latest transaction was disclosed on 23 June 2026 (Other). Among the most active insiders: 이환철. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
엘앤씨바이오 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.